MKM Starts BioSpecifics Technologies (BSTC) at Buy, Sets $26.50 Target
Tweet Send to a FriendGet Alerts BSTC Hot Sheet
Price: $15.79 -0.5%
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade BSTC Now!
MKM Partners initiated coverage on BioSpecifics Technologies (NASDAQ: BSTC) with a Buy rating and a $26.50 price target.
For an analyst ratings summary and ratings history on BioSpecifics Technologies click here. For more ratings news on BioSpecifics Technologies click here.
Shares of BioSpecifics Technologies closed at $15.92 Wednesday, with a 52 week range of $12.68-$26.01.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on BioSpecifics Technologies click here. For more ratings news on BioSpecifics Technologies click here.
Shares of BioSpecifics Technologies closed at $15.92 Wednesday, with a 52 week range of $12.68-$26.01.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Deutsche Bank Resumes CenterPoint Energy (CNP) at Hold
- Janney Capital Boosts PT on Gap (GPS) Post Q1
- Wedbush Downgrades salesforce.com (CRM) to Neutral
Create E-mail Alert Related Categories
New Coverage
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
